You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-CD45RO antibody [1.BB.437] (Phycoerythrin) (ab63482)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-CD45RO antibody [1.BB.437] (Phycoerythrin)
See all CD45RO products (9) ...

Description

Mouse monoclonal [1.BB.437] to CD45RO (Phycoerythrin)

Conjugation

Phycoerythrin

Conjugation notes

R-phycoerythrin has an absorbance maximum of 565.5nm with an emission maximum at 578nm. This fluorochrome has been covalently conjugated and puried chromatographically to remove unconjugated antibody and dye, while achieving a fluorochrome/protein (F/P) molar ratio between 1.06.

Specificity

ab63482 recognizes the low molecular weight isoform of the leukocyte common antigen (LCA) (CD45RO).

Tested applications

IHC-P, IHC-Fr, Flow Cytmore details

Cross reactivity

Reacts with

Human

Immunogen

IL-2 dependent T-cell line CA1

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Add glycerol to a final volume of 50%, aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.1% Sodium Azide
Constituents: 1% BSA, PBS, 2mM EDTA, pH 7.2

Concentration

Concentration information loading...

Purity

Protein A purified

Clonality

Monoclonal

Clone number

1.BB.437

Isotype

IgG2a

Applications

Show applications key

Our Abpromise guarantee covers the use of ab63482 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • IHC-P

     
  • IHC-Fr

     
  • Flow Cyt

     

Application notes

Flow Cyt: Use 1µg for 106 cells.
IHC-P: Use at an assay dependent dilution. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
IHC-Fr: Use at an assay dependent dilution.
IHC-Cell suspensions: Use at an assay dependent dilution.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN. Dephosphorylates LYN, and thereby modulates LYN activity.

Involvement in disease

Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain.

Sequence similarities

Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.
Contains 2 fibronectin type-III domains.
Contains 2 tyrosine-protein phosphatase domains.

Domain

The first PTPase domain interacts with SKAP1.

Post-translational
modifications

Heavily N- and O-glycosylated.

Cellular localization

Membrane. Membrane raft. Colocalized with DPP4 in membrane rafts.

Target information above from: UniProt accessionP08575 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • B220 antibody
  • CD 45 antibody
  • CD45 antibody
  • cd45 antigen antibody
  • ec3.1.3.48 antibody
  • GP 180 antibody
  • GP180 antibody
  • Human homolog of severe combined immunodeficiency due to PTPRC deficiency antibody
  • L CA antibody
  • L-CA antibody
  • lca antibody
  • Leukocyte common antigen antibody
  • LY 5 antibody
  • LY5 antibody
  • Protein tyrosine phosphatase receptor type C antibody
  • Protein tyrosine phosphatase receptor type c polypeptide antibody
  • PTPRC antibody
  • PTPRC_HUMAN antibody
  • Receptor-type tyrosine-protein phosphatase C antibody
  • SCID due to PTPRC deficiency antibody
  • t200 antibody
  • T200 glycoprotein antibody
  • T200 leukocyte common antigen antibody
see all

References for Anti-CD45RO antibody [1.BB.437] (Phycoerythrin) (ab63482)

ab63482 has not yet been referenced specifically in any publications.

Publishing research using ab63482? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"